161 related articles for article (PubMed ID: 3052654)
21. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.
Perrot-Applanat M; Groyer-Picard MT; Lorenzo F; Jolivet A; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Cancer Res; 1987 May; 47(10):2652-61. PubMed ID: 2436753
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
Thorpe SM
Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
[TBL] [Abstract][Full Text] [Related]
24. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
Itoh E
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
26. [Determination of estradiol receptors by immunoenzyme technique and by radioligand binding in 2134 breast tumors].
Romain S; Dussert C; Martin PM
Bull Cancer; 1991; 78(4):331-40. PubMed ID: 1713518
[TBL] [Abstract][Full Text] [Related]
27. The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer.
Lozowski M; Greene GL; Sadri D; Stanick D; Pai P; Harris MA; Lundy J
Acta Cytol; 1990; 34(1):27-30. PubMed ID: 2404374
[TBL] [Abstract][Full Text] [Related]
28. Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols.
Foekens JA; Portengen H; van Driel J; van Putten WL; Haije WG; Klijn JG
J Steroid Biochem; 1988 Jun; 29(6):571-4. PubMed ID: 3290577
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.
Charpin C; Jacquemier J; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M
Am J Pathol; 1988 Aug; 132(2):199-211. PubMed ID: 2456699
[TBL] [Abstract][Full Text] [Related]
31. [Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer].
Ohnami S; Nakayama C; Ohnami S; Zeze F; Eto S
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3447-52. PubMed ID: 3539025
[TBL] [Abstract][Full Text] [Related]
32. [Estrogen receptors in cancer of the breast. Comparison of 2 methods].
Delarue JC; Mouriesse H; Contesso G; Bonnay M; May-Levin F; Sancho-Garnier H; Travagli JP; Lacombe MJ
Ann Biol Clin (Paris); 1986; 44(6):629-33. PubMed ID: 3548499
[TBL] [Abstract][Full Text] [Related]
33. Quality control requirements in estrogen receptor determination.
Bojar H
Cancer Res; 1986 Aug; 46(8 Suppl):4249s-4250s. PubMed ID: 3524806
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.
Perrot-Applanat M; Groyer-Picard MT; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Am J Pathol; 1989 Sep; 135(3):457-68. PubMed ID: 2675623
[TBL] [Abstract][Full Text] [Related]
35. Characterization of progesterone receptor A and B expression in human breast cancer.
Graham JD; Yeates C; Balleine RL; Harvey SS; Milliken JS; Bilous AM; Clarke CL
Cancer Res; 1995 Nov; 55(21):5063-8. PubMed ID: 7585552
[TBL] [Abstract][Full Text] [Related]
36. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical study using monoclonal antibodies (H222 SP gamma) of estrogen receptors: correlation with biochemical analysis (by radioligand) of 115 breast carcinomas].
Jacquemier J; Charpin C; Martin PM
Bull Cancer; 1986; 73(2):107-19. PubMed ID: 3524713
[TBL] [Abstract][Full Text] [Related]
38. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.
Andersen J; Bentzen SM; Poulsen HS
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322
[No Abstract] [Full Text] [Related]
40. [Immunohistochemical determination of estrogen receptors in breast carcinoma tissue using monoclonal antibodies. 1st clinical findings].
Jonat W; Stegner HE; Maass H
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):473-6. PubMed ID: 3896915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
